In the wake of the Patient Protection and Affordable Care Act of 2010, many provider organizations (e.g., hospitals and physician groups) have responded to the changing health care delivery environment by seeking safety in size through mergers and acquisitions. Payers are also buying or creating partnerships with hospitals, and hospitals are acquiring other hospitals and physician practices to become entire health systems. As payers and providers consolidate in order to use their market share to negotiate with manufacturers, how do biotech companies adapt? Gain insight into payer and provider strategies and recommendations for how biotech companies can sustain growth in the face of market consolidation and push back on utilization and reimbursement constraints. Panelists will share how innovation – not consolidation and regulation – may be the real path to better health care.

Learning Objectives:

  • Analyze the drivers of payer and provider consolidation
  • Evaluate how consolidation is happening and how new organizations will be structured
  • Define the implications for biotech and how to respond

Ability Level: All

Session ID: 1884

myBIO Chatter

Speakers (2)

contact_8363 Marc Boutin Executive Vice President & Chief Operating Officer National Health Council
contact_9611 Paul Howard Director, Center for Medical Progress Manhattan Institute

Moderators (1)

contact_4833 Rita Numerof President Numerof & Associates, Inc.